Why Is Fusion Pharmaceuticals Stock Trading Higher Today? – AstraZeneca (NASDAQ:AZN), Fusion Pharmaceuticals (NASDAQ:FUSN)
Tuesday, AstraZeneca Plc AZN agreed to acquire Fusion Pharmaceuticals Inc FUSN for $21.00 per share in cash plus a non-transferable contingent value right (CVR) of $3.00 per share in cash payable upon the achievement of a specified regulatory milestone.The upfront cash portion of the consideration represents a transaction value of approximately $2 billion, a 97% premium to Fusion’s closing market … Read more